HSBC analyst Rajesh Kumar upgrades AbbVie (NYSE:ABBV) from Hold to Buy and announces $185 price target.
HSBC Upgrades AbbVie to Buy, Announces $185 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.